Clinical response to imatinib mesylate in recurrent and metastatic gastrointestinal stromal tumors

被引：0
作者：
Villalobos, R. [1 ]
Hernandez, G. [1 ]
Martinez-Prieto, M. [1 ]
Silva, A. [1 ]
机构：
[1] UMAE Hosp Oncol CMN Siglo XXI, Mexico City, DF, Mexico
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
20528
引用
收藏
页数：1
相关论文
共 50 条
[31]   Survival benefit of imatinib mesylate on patients with advanced gastrointestinal stromal tumors (GIST) [J].
Lin, M. T. ;
Hu, T. H. ;
Lin, J. W. ;
Wang, C. C. ;
Rau, K. M. ;
Changchien, C. S. .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 :A44-A44
[32]   Complete pathological response to Imatinib mesylate in an extraintestinal gastrointestinal stromal tumor [J].
Quezada, Nicolas ;
Acevedo, Francisco ;
Marambio, Andres ;
Leon, Felipe ;
Galindo, Hector ;
Roa, Juan Carlos ;
Jarufe, Nicolas .
INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2014, 5 (10) :681-685
[33]   Gene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumor [J].
Rink, Lori ;
Skorobogatko, Yuliya ;
Kossenkov, Andrew V. ;
Belinsky, Martin G. ;
Pajak, Thomas ;
Heinrich, Michael C. ;
Blanke, Charles D. ;
von Mehren, Margaret ;
Ochs, Michael F. ;
Eisenberg, Burton ;
Godwin, Andrew K. .
MOLECULAR CANCER THERAPEUTICS, 2009, 8 (08) :2172-2182
[34]   Immediate action of imatinib mesylate on calcium signaling in gastrointestinal stromal tumors (GIST) [J].
Berglund, E. ;
Lu, M. ;
Akcakaya, P. ;
Zedenius, J. ;
Nilsson, I. ;
Ahlen, J. ;
Lui, W. ;
Larsson, C. ;
Branstrom, R. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[35]   Approval Summary: Imatinib Mesylate in the Adjuvant Treatment of Malignant Gastrointestinal Stromal Tumors [J].
Cohen, Martin H. ;
Cortazar, Patricia ;
Justice, Robert ;
Pazdur, Richard .
ONCOLOGIST, 2010, 15 (03) :300-307
[36]   Imatinib mesylate in the treatment of gastrointestinal stromal tumour [J].
Steinert, DM ;
McAuliffe, JC ;
Trent, JC .
EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (01) :105-113
[37]   Survival from metastatic gastrointestinal stromal tumors in the era of imatinib [J].
Artinyan, A. ;
Kim, J. ;
Soriano, P. ;
Ellenhorn, J. .
ANNALS OF SURGICAL ONCOLOGY, 2008, 15 :92-92
[38]   Imatinib discontinuation in patients with metastatic gastrointestinal stromal tumors (GISTs) [J].
de Pas, Tommaso ;
Biffi, Roberto ;
Mazzarol, Giovanni ;
Della Vigna, Paolo ;
Travaini, Laura ;
Curigliano, Giuseppe ;
Formica, Vincenzo ;
de Braud, Filippo .
ANNALS OF ONCOLOGY, 2004, 15 :201-201
[39]   Efficacy of imatinib mesylate in from gastrointestinal stromal [J].
Fiorentini, G ;
Bernardeschi, P ;
De Simone, M ;
Rossi, S ;
Dentico, P ;
Biancalani, M ;
Scuderi, S ;
Vaira, M ;
Palomba, A .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2003, 22 (04) :13-16
[40]   Imatinib mesylate for the treatment of gastrointestinal stromal tumor [J].
Cassier, Philippe A. ;
Blay, Jean-Yves .
EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (05) :623-634
12345